Boston, MA 06/13/2013 (wallstreetpr) – The share prices of GenMark Diagnostics, Inc (NASDAQ:GNMK) had been traded in the price range of $11.50 and $13.33 on Wednesday. The company’s share price had had gradually decreased by 7.06 percentage less than the previous day. The opening price is $13.31, which is about to a net change of nearly $0.93 less. The share price of GenMark Diagnostics, Inc (NASDAQ:GNMK) had no effect in the 52 week high value $13.33 and 52 week low value $4.02.
The company GenMark Diagnostics, Inc (NASDAQ:GNMK) is a molecular diagnostic company. It mainly focuses on developing and commercialization of eSensor detection technology. The company had 72 distinct biomarkers in a single sample. Its XT-8 System, ehich supports molecular diagnostic test with compact workstation. It has received the clearance from the United States Food and Drug Administration (FDA). The XT-8 System supports 24 test cartridge which works independently. It is targeted in hospitals and laboratories and they are planning to produce next generation platform. The AD-8 System which integrates DNA amplification with eSensor detection technology.
The GenMark Diagnostics, Inc (NASDAQ:GNMK) has currently presented the Annual Growth Stock Conference in Chicago. The company has given the buy rating at Canaccord Genuity. This result has announced on Tuesday. Canaccord Genuity’s target price points to a potential upside of 36.67%. The researcher has analysed that the target price of $16.17. The stock’s 50 days moving average with a company’s market cap is $431.6 million
The market capitalization value is about 401.11 million and institutional investors share’s percentage is about 78. The GenMark Diagnostics, Inc (NASDAQ:GNMK) been contain a trading volume as 2.02 million and the average volume as 253,256 per day on Wednesday. The company presently holds 32.77 million shares outstanding in the market. The risk to investors with market or other economic reason is about 0.59.
